TDP-43 phase separation therapeutics for ALS-FTD — Analysis Notebook

CI-generated notebook stub for analysis sda-2026-04-01-gap-006. TDP-43 undergoes liquid-liquid phase separation that becomes pathological. Small molecules targeting phase separation properties could be therapeutic but the design principles are

📊 Related Analysis: TDP-43 phase separation therapeutics for ALS-FTD (neurodegeneration)
Created: 2026-04-16
Download .ipynb